- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Aurobindo Pharma Ltd. (ARBN)
1,666.90
-11.00(-0.66%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,655.00
1,681.70
52 wk Range
1,080.10
1,740.00
ARBN Technical Analysis
Analyze ARBN technical analysis, including key indicators like ARBN RSI and ARBN moving averages. Track the ARBN 50 day moving average and ARBN 200 day moving average to assess short-term and long-term trends while identifying ARBN buy or sell signals. This page provides a comprehensive breakdown of ARBN technical indicators to help evaluate Aurobindo Pharma's performance.
Summary:Sell
| Moving Averages: | Sell | Buy: (2) | Sell: (10) |
| Technical Indicators: | Sell | Buy: (3) | Sell: (4) |
Technical Indicators
Summary: SellBuy: 3Neutral: 4Sell: 4
Oct 17, 2026 09:31AM GMT
Name | Value | Action | ||
|---|---|---|---|---|
| RSI(14) | 46.394 | Neutral | ||
| STOCH(9,6) | 35.243 | Sell | ||
| STOCHRSI(14) | 48.061 | Neutral | ||
| MACD(12,26) | -3.323 | Sell | ||
| ADX(14) | 18.423 | Neutral | ||
| Williams %R | -46.409 | Neutral | ||
| CCI(14) | -55.4386 | Sell | ||
| ATR(14) | 11.2444 | Less Volatility | ||
| Highs/Lows(14) | 1.3000 | Buy | ||
| Ultimate Oscillator | 54.926 | Buy | ||
| ROC | 0.241 | Buy | ||
| Bull/Bear Power(13) | -12.2677 | Sell | ||
Moving Averages
Summary: SellBuy: 2Sell: 10
Oct 17, 2026 09:31AM GMT
Name | Simple | Exponential | |||
|---|---|---|---|---|---|
| MA5 | 1,664.90 Buy | | 1,665.99 Buy | | |
| MA10 | 1,669.19 Sell | | 1,667.69 Sell | | |
| MA20 | 1,670.01 Sell | | 1,670.47 Sell | | |
| MA50 | 1,673.75 Sell | | 1,674.86 Sell | | |
| MA100 | 1,680.13 Sell | | 1,678.25 Sell | | |
| MA200 | 1,682.47 Sell | | 1,673.68 Sell | | |
Pivot Points
Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Classic | 1,656.07 | 1,658.53 | 1,661.87 | 1,664.33 | 1,667.67 | 1,670.13 | 1,673.47 |
| Fibonacci | 1,658.53 | 1,660.75 | 1,662.12 | 1,664.33 | 1,666.55 | 1,667.92 | 1,670.13 |
| Camarilla | 1,663.61 | 1,664.14 | 1,664.67 | 1,664.33 | 1,665.73 | 1,666.26 | 1,666.80 |
| Woodie's | 1,656.50 | 1,658.75 | 1,662.30 | 1,664.55 | 1,668.10 | 1,670.35 | 1,673.90 |
| DeMark's | - | - | 1,663.10 | 1,664.95 | 1,668.90 | - | - |
FAQ
From a Technical Analysis Perspective, Is Aurobindo Pharma a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
How Do the Moving Averages for AUROPHARMA Currently Stand?
The moving averages for Aurobindo Pharma show a Neutral outlook, considering moving averages ranging from MA5 to MA200, with 6 Buy signals and 6 Sell signals.
What Is the Current Status of the Technical Indicators for Aurobindo Pharma?
The technical indicators for Aurobindo Pharma are in a Sell position based on daily analysis, with 2 signals on buy indicators and 7 sell signals.
What Is AUROPHARMA's 14-Day RSI?
The current Relative Strength Index (RSI) of AUROPHARMA over the 14-day period is 46.394, which suggests that the stock is a Neutral.
What Is AUROPHARMA's MACD?
AUROPHARMA's MACD is -3.323, which suggests that the stock is a Sell.
What Is AUROPHARMA's 5-Day Moving Average?
AUROPHARMA's 5-day moving average is 1,664.90, suggesting that the stock is a Buy.
What Is AUROPHARMA's 50-Day Moving Average?
AUROPHARMA's 50-day moving average is 1,673.75, suggesting that the stock is a Sell.
What Is AUROPHARMA's 200-Day Moving Average?
AUROPHARMA's 200-day moving average is 1,682.47, suggesting that the stock is a Sell.
What Is the Fibonacci Pivot Point Performance Value for AUROPHARMA?
The Fibonacci pivot point performance value for AUROPHARMA is 1,664.33.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.